tenofovir has been researched along with AIDS Seroconversion in 86 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (12.79) | 29.6817 |
2010's | 54 (62.79) | 24.3611 |
2020's | 21 (24.42) | 2.80 |
Authors | Studies |
---|---|
Antoniak, S; Begovac, J; Dragovic, G; Fleischhans, L; Gokengin, D; Harxhi, A; Hofman, S; Jilich, D; Kase, K; Kowalska, J; Lakatos, B; Matulionyte, R; Oprea, C; Papadopoulus, A; Rukhadze, N; Vassilenko, A; Vasyliev, M; Verhaz, A; Wasilewski, P; Yancheva, N | 1 |
Abdool Karim, Q; Abdool Karim, SS; Garrett, NJ; McKinnon, LR; Molatlhegi, RP; Ngcapu, S; Ngcobo, S; Osman, F; Samsunder, N; Sivro, A | 1 |
Abdi, B; Bitilinyu-Bangoh, JE; Calvez, V; Descamps, D; Jahn, A; Kalua, T; Lê, MP; Marcelin, AG; Nicholas, S; Ousley, J; Peytavin, G; Schramm, B; Storto, A; Szumilin, E; Temfack, E | 1 |
Cai, L; Guo, Z; He, S; Wang, Y; Wang, Z; Yan, D; Yang, X; Zheng, Y | 1 |
Baxter, C; Beyer, A; Derkach, E; Lobodina, A; Pyadushkina, E; Rozenberg, V; Ugrekhelidze, D | 1 |
Aurpibul, L; Best, BM; Campbell, H; Cassim, H; Cooper, E; Flynn, P; Gray, KP; Krotje, C; McCarthy, K; McFarland, E; Melvin, AJ; Moye, J; Ounchanum, P; Rungmaitree, S; Scheckter, R; Teppler, H; Tobin, NH; Townley, E; Wan, H; Yedla, M; Yee, KL | 1 |
Aubert, A; Bani-Sadr, F; Berger, JL; Hittinger Roux, A; N'Guyen, Y | 1 |
Bradford, Y; Chandiwana, NC; Haas, DW; Maartens, G; Mateza, S; Post, FA; Ritchie, MD; Sinxadi, P; Sokhela, S; Venter, WDF | 1 |
Callebaut, C; Cox, S; Margot, N | 1 |
Eleje, GU; Ikechebelu, JI; Nwagha, UI; Okafor, HU; Ugwu, AO; Ugwu, EO; Umeh, UA | 1 |
Berni, A; Castagna, A; Cazanave, C; Chounta, V; D'Amico, R; Di Perri, G; Diaz-Brito, V; Dretler, R; Garges, HP; Latham, CL; Oka, S; Osiyemi, O; Pascual Bernáldez, M; Patel, P; Ramgopal, MN; Sims, J; Smith, K; Spreen, WR; Sutherland-Phillips, D; Sutton, K; Van Eygen, V; Van Solingen-Ristea, R; van Wyk, J; Walmsley, S; Zhang, F | 1 |
Almangour, TA; Chang, PP; Corbett, A; Farel, CE; Rodgers, JE; Skersick, PT | 1 |
Ajeh, R; Beloumou, G; Bouba, NP; Cappelli, G; Ceccherini-Silberstein, F; Chenwi, CA; Colizzi, V; Dambaya, B; Djupsa, S; Fokam, J; Kembou, E; Mbanya, D; Ndjolo, A; Perno, CF; Santoro, MM; Semengue, ENJ; Takou, D; Tala, V; Teto, G | 1 |
Gandhi, M; Herbertson, EC; Lahiri, CD; Olugbake, OA; Soremekun, RO; Spinelli, MA | 1 |
Chuang, YC; Hung, CC; Kuo, PH; Liu, WC; Sun, HY; Wu, PY | 1 |
Chen, Y; Lu, Y; Tao, X; Zhang, L; Zhou, Y | 1 |
Bailey, AC; Mackie, N; Muir, D; Ring, K | 1 |
Anderson, PL; Chan, DPC; Kwan, TH; Lam, TTN; Lee, KCK; Lee, SS; Lui, GCY; Wong, NS | 1 |
Dickens, C; Duarte, R; Hassan, MO; Lasisi, AO; Mabayoje, VO; Naicker, S | 1 |
Ambrosioni, J; Laguno, M; Liegeon, G; Miró, JM; Petit, E | 1 |
Andreatta, K; Berger, D; Blair, C; Brainard, DM; Brar, I; Collins, SE; Hagins, D; Hileman, CO; Kumar, P; Martin, H; McDonald, C; Osiyemi, O; Ramgopal, MN; Saag, M; Wurapa, AK | 1 |
Agingu, W; Ahmed, K; Crucitti, T; de Baetselier, I; Deese, J; Fransen, K; Owino, F; Rammutla, E; Van Damme, L; Venter, G | 1 |
Bias, TE; Boyle, SM; Doyle, AM; Harhay, MN; Lee, DH; Malat, G; Pang, L; Ranganna, K; Sharma, A; Talluri, S | 1 |
Balkus, J; Elharrar, V; Husnik, M; Jeenarain, N; Kabwigu, S; Levy, L; Livant, E; Mhlanga, F; Nair, G; Palanee-Phillips, T; Panchia, R; Pather, A; Patterson, K; Premrajh, A; Ramjee, G; Riddler, SA; Selepe, P; Siva, S; Tutshana, BO | 1 |
Baeten, JM; Balkus, JE; Bukusi, E; Celum, C; Cohen, CR; Donnell, D; Fiedler, T; Fredricks, DN; Heffron, R; Kiarie, J; Lingappa, J; McClelland, RS; Mugo, N; Munch, M | 1 |
Achterbergh, RCA; Anderson, PL; Cornelissen, M; de Bree, GJ; de Vries, HJC; Hoornenborg, E; Jurriaans, S; Kootstra, NA; Prins, JM; Prins, M; Reiss, P; Woittiez, LR | 1 |
Balestre, E; Bärnighausen, T; Bazin, B; Boyer, S; Dabis, F; De Oliveira, T; Dreyer, J; Herbst, K; Iwuji, CC; Larmarange, J; Makowa, T; McGrath, N; Newell, ML; Okesola, N; Orne-Gliemann, J; Pillay, D; Rekacewicz, C; Tanser, F; Thiebaut, R | 1 |
Andreatta, K; Brar, I; Brinson, C; Cheng, A; Custodio, J; Liu, H; López-Cortés, L; Martin, H; Mills, A; Molina, JM; Podzamczer, D; Quirk, E; Ruane, P; Stellbrink, HJ; Ward, D | 1 |
Ananworanich, J; Colby, DJ; Gandhi, M; Grant, RM; Kroon, E; Phanuphak, N; Phanuphak, P; Robb, ML; Sacdalan, C | 1 |
Bogner, JR; Gomez, M; Härter, G; Roider, J; Seybold, U | 1 |
Baldin, G; Belmonti, S; Borghetti, A; Ciccullo, A; De Luca, A; Di Giambenedetto, S; Emiliozzi, A; Gagliardini, R; Lamonica, S; Lombardi, F; Montagnani, F; Moschese, D; Visconti, E | 1 |
Brown, TT; Díez-Pérez, A; García-Giralt, N; González-Mena, A; Güerri-Fernández, R; Knobel, H; Lerma-Chippirraz, E; Pineda-Moncusí, M; Soldado-Folgado, J; Trenchs-Rodríguez, M | 1 |
Abebo, TA; Altaye, AA; Asfaw, FT; Bekele, FB; Hibistu, DT; Kebede, HG; Laelago, T; Lukas, K; Tesfaye, DJ; Turuse, EA | 1 |
Abgrall, S; Antinori, A; Cavassini, M; Costagliola, D; Crane, HM; Gill, MJ; Gomez Sirvent, JL; Guest, JL; Ingle, SM; Manzardo, C; May, MT; Mercie, P; Mugavero, MJ; Phillips, A; Reekie, J; Reiss, P; Saag, MS; Samji, H; Stephan, C; Sterling, TR; Sterne, JA; Tate, J; Wasmuth, JC | 1 |
Charlwood, L; Gilleece, Y; Home, J; Howell, R; Keith, T; McInnes, C; Payne, E; Taylor, S; Whetham, J; White, D | 1 |
Baeten, JM; Bangsberg, DR; Campbell, J; Celum, C; Donnell, D; Haberer, JE; Katabira, E; Kidoguchi, L; Krows, M; Psaros, C; Ronald, A; Safren, SA; Thomas, KK; Tumwesigye, E; Wangisi, J; Ware, NC | 1 |
Cox, AP; Delany-Moretlwe, S; Foss, AM; Heise, L; Mertenskoetter, T; Meyer-Rath, G; Rees, H; Terris-Prestholt, F; Vickerman, P; Watts, CH | 1 |
Baeten, JM; Bangsberg, DR; Brantley, J; Bumpus, NN; Celum, C; Donnell, D; Haberer, JE; Hendrix, C; Mugo, N; Mujugira, A; Ndase, P | 1 |
Chima-Okereke, C; Sivaprakasam, V | 1 |
Gürtler, LG | 1 |
Borsa-Lebas, F; Cacoub, P; Carrat, F; Fillion, A; Lacombe, K; Lopes, A; Loustaud-Ratti, V; Miailhes, P; Piroth, L; Pol, S; Rosenthal, E; Salmon, D | 1 |
Baeten, JM; Celum, C; Donnell, D; Frenkel, L; Hendrix, CW; Lehman, DA; Marzinke, MA; Matsen, FA; Mbara, G; McCoy, CO; Mugo, NR; Ndase, P; Overbaugh, J; Peterson, D; Thomas, KK; Weis, JF | 1 |
Baeten, JM; Celum, C; Cremin, I; Delany-Moretlwe, S; Hallett, TB; Jewell, BL; Pickles, M | 1 |
Chirenje, ZM; Dai, JY; Ganesh, S; Gomez, K; Grossman, C; Hendrix, CW; Hillier, SL; Marrazzo, JM; Marzinke, MA; Mâsse, B; McGowan, IM; Mgodi, N; Mkhize, B; Nair, G; Nakabiito, C; Noguchi, L; Palanee, T; Parikh, UM; Piper, J; Ramjee, G; Richardson, BA; Rooney, J; Schwartz, JL; Taljaard, M; van der Straten, A; Watts, H | 1 |
Boissonnault, M; Charest, L; Galanakis, C; Huchet, E; Longpré, D; Machouf, N; Murphy, D; Thomas, R; Trottier, B; Vézina, S | 1 |
Alioni, S; Izudi, J; Kerukadho, E; Ndungutse, D | 1 |
Asari, V; Baxter, C; Garrett, N; Grobler, A; Karim, QA; Karim, SSA; Majola, N; Naicker, N; Naidoo, A; Werner, L | 1 |
Carrington, M; Davis, B; Duh, FM; Jean-Pierre, P; La Roche, M; Markowitz, M; Mehandru, S; Mohri, H; Poles, M; Prada, N | 1 |
Cosyns, JP; Jadoul, M; Jouret, F; Labriola, L; Lambert, M; Morelle, J | 1 |
Beniowski, M; De Wit, S; Gatell, J; Kirk, O; Ledergerber, B; Lundgren, JD; Mocroft, A; Phillips, AN; Reiss, P; Sedlacek, D | 1 |
Baleta, A | 1 |
Amico, KR; Anderson, PL; Bekker, LG; Buchbinder, SP; Burns, DN; Bushman, LR; Casapía, M; Chariyalertsak, S; Defechereux, P; Fernández, T; Ganoza, C; Glidden, DV; Goicochea, P; Grant, RM; Guanira-Carranza, JV; Hance, RJ; Jaffe, HS; Kallás, EG; Lama, JR; Lee, J; Liu, AY; Martinez, AI; Mayer, KH; McConnell, JJ; McMahan, V; Montoya-Herrera, O; Mulligan, K; Postle, B; Ramirez-Cardich, ME; Rooney, JF; Schechter, M; Vargas, L; Veloso, VG; Wang, F; Zheng, JH | 1 |
Brooks, JT; Bush, T; Conley, L; Hammer, J; Henry, K; Kojic, EM; Mondy, K; Overton, ET; Patel, P; Rhame, F | 1 |
Gutiérrez, F; López, N; Masiá, M; Padilla, S; Ramos, JM; Robledano, C | 1 |
Hakim, JG; Katsidzira, L | 1 |
Baietto, L; Bonora, S; Calcagno, A; D'Avolio, A; Di Perri, G; Gonzalez de Requena, D; Siccardi, M; Simiele, M; Tettoni, M; Trentini, L | 1 |
Donnelly, J | 1 |
Ananthakrishnan, S; Garg, A; Levine, D | 1 |
Vere Hodge, A | 1 |
Baeten, JM; Barnes, L; Bukusi, E; Campbell, JD; Celum, C; Cohen, CR; Coombs, RW; Donnell, D; Farquhar, C; Fife, KH; Ingram, C; John-Stewart, G; Katabira, E; Kiarie, J; Kidoguchi, L; Krows, M; Lingappa, JR; Morrison, S; Mugo, NR; Mujugira, A; Ndase, P; Ondrejcek, L; Panteleeff, D; Revall, J; Ronald, A; Shah, H; Tappero, JW; Tumwesigye, E; Wangisi, J; Were, E | 1 |
Cellini, M; Gabiano, C; Giacomet, V; Manfredini, V; Mora, S; Puzzovio, M; Salvini, F; Stucchi, S; Tamburrini, E; Viganò, A; Zuccotti, GV | 1 |
Baeten, JM; Bangsberg, DR; Celum, CL; Haberer, JE; Kintu, A; Psaros, C; Safren, S; Tumwesigye, E; Ware, NC; Wyatt, MA | 1 |
Belda, A; Borrás-Blasco, J; Casterá, E; Jiménez, I; López-Montes, L; Rosique-Robles, D | 1 |
Bech, A; De Boer, H; Gisolf, J; Nabbe, K; Richter, C; Van Bentum, P | 1 |
Chidziva, E; Gibb, DM; Gilks, CF; Grosskurth, H; Hakim, J; Kizito, H; Kyomugisha, H; Munderi, P; Musoke, P; Nalumenya, R; Nathoo, K; Russell, EC; Spyer, M; Tumukunde, D; Walker, AS; Zalwango, E | 1 |
Gordon, M; Hampton, J; Johnson, B; Kuritzkes, DR; Marconi, VC; Moosa, MY; Ordonez, C; Sunpath, H; Wu, B | 1 |
Abdool Karim, Q; Abdool Karim, SS; Altfeld, M; Carr, WH; Naranbhai, V; Ndung'u, T | 1 |
Abebe, D; Brooks, JT; Buliva, E; Chillag, KL; Chirwa, LI; Gvetadze, RJ; Hart, C; Henderson, FL; Hendrix, CW; Johnson, JA; Johnson, S; Kasonde, M; Kebaabetswe, PM; Malotte, CK; Mutanhaurwa, R; Pathak, SR; Paxton, LA; Rose, CE; Segolodi, TM; Smith, DK; Soud, FA; Sukalac, T; Thigpen, MC; Thomas, VT | 1 |
Agot, K; Ahmed, K; Corneli, A; Crucitti, T; Deese, J; Fransen, K; Grant, R; Kapiga, S; Kashuba, A; Kiernan, H; Kirkendale, S; Lombaard, J; Mak'Oketch, P; Makanda, M; Makatu, SE; Malahleha, M; Mandala, J; Manongi, R; Mastro, TD; Monedi, MC; Nanda, K; Onyango, J; Owino, F; Reblin, I; Saylor, L; Taylor, D; Temu, L; Van Damme, L; Wong, C | 1 |
Apaka, C; Baeten, JM; Bangsberg, D; Bukusi, EA; Bumpus, NN; Campbell, JD; Celum, C; Cohen, CR; Coombs, RW; Donnell, D; Emmanuel-Ogier, M; Farquhar, C; Fife, KH; Frenkel, L; Gabona, F; Haberer, JE; Haugen, H; Hendrix, C; John-Stewart, G; Kakia, A; Katabira, E; Kiarie, J; Kidoguchi, L; Krows, M; Lingappa, JR; Morrison, S; Mucunguzi, A; Mugo, NR; Mujugira, A; Nakku-Joloba, E; Ndase, P; Ngure, K; Odoyo, J; Ondrejcek, L; Panteleeff, D; Revall, J; Ronald, A; Stevens, WS; Tamooh, H; Tappero, JW; Thomas, KK; Tumwesigye, E; Twesigye, R; Wangisi, J; Were, E | 1 |
Crane, HM; Eron, JJ; Kalayjian, RC; Kitahata, MM; Krishnasami, Z; Lau, B; Martin, JN; Mechekano, RN; Moore, RD; Rodriguez, B; Salata, RA; Willig, JH | 1 |
Arribas, JR; Bernardino, JI; Estebanez, M; García-Bujalance, S; Martin-Quirós, A; Mingorance, J; Pérez-Valero, I; Ruiz-Carrascoso, G; Stella-Ascariz, N; Zamora, FX | 1 |
Firnhaber, C; Maskew, M; Sanne, I; Westreich, D | 1 |
Gatanaga, H; Gomibuchi, H; Hosokawa, S; Kikuchi, Y; Kinai, E; Oka, S | 1 |
Abimiku, A; Ajayi, S; Blattner, WA; Carr, JK; Chang, H; Charurat, M; Elegba, O; Etiebet, MA; Eyzaguirre, LM; Ndembi, N; Nowak, RG; Shepherd, J | 1 |
Baril, JG; Dufresne, S; Laprise, C; Trottier, H | 1 |
Ingiliz, P; Ivanka, K; Krznaric, I; Martin, O; Obermeier, M; Patrick, I | 1 |
Fouqueray, B; Girard, PM; Meynard, JL; Monge, M; Mougenot, B; Ronco, P; Rossert, J; Verhelst, D | 1 |
Callens, S; Colebunders, R; De Roo, A | 1 |
de Guzmán, M; García-Reyne, A; Gaspar, G; Monereo, A | 1 |
Forbes, A | 1 |
Rimland, D; Rouphael, NG; Talati, NJ | 1 |
Anastos, K; Cohen, M; Cole, S; Hessol, NA; Justman, J; Kaplan, RC; Lu, D; Shi, Q; Tien, PC; Vigen, C; Young, M | 1 |
Hope, T; Jaffe, HW; Paxton, LA | 1 |
6 review(s) available for tenofovir and AIDS Seroconversion
Article | Year |
---|---|
Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
Topics: Antiviral Agents; Coinfection; DNA, Viral; Emtricitabine; Female; Hepatitis B e Antigens; Hepatitis B virus; HIV; HIV Infections; HIV Seropositivity; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Pregnancy; Pregnant Women; Ritonavir; Tenofovir; Zidovudine | 2023 |
Efficacy and safety of the regimens containing tenofovir alafenamide versus tenofovir disoproxil fumarate in fixed-dose single-tablet regimens for initial treatment of HIV-1 infection: A meta-analysis of randomized controlled trials.
Topics: Adenine; Adult; Alanine; Anti-HIV Agents; CD4 Lymphocyte Count; HIV Infections; HIV Seropositivity; HIV-1; Humans; Kidney; Randomized Controlled Trials as Topic; Tablets; Tenofovir | 2020 |
Primary HIV-1 infection in users of pre-exposure prophylaxis.
Topics: Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; HIV Seropositivity; HIV-1; Humans; Pre-Exposure Prophylaxis; Tenofovir; Viral Load | 2021 |
HIV prevention in southern Africa: why we must reassess our strategies?
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adolescent; Adult; Anti-HIV Agents; Circumcision, Male; Condoms; Condoms, Female; Female; HIV Infections; HIV Seropositivity; Humans; Interdisciplinary Communication; Male; Middle Aged; Organophosphonates; Preventive Medicine; Risk Reduction Behavior; Tenofovir; Young Adult | 2011 |
Hepatitis B reverse seroconversion in HIV-positive patients: case series and review of the literature.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; HIV Seropositivity; Humans; Lamivudine; Middle Aged; Organophosphonates; Tenofovir | 2007 |
Pre-exposure prophylaxis for HIV infection: what if it works?
Topics: Adenine; Anti-HIV Agents; Attitude of Health Personnel; Drug Administration Schedule; Female; HIV Infections; HIV Seropositivity; Humans; Male; Organophosphonates; Public Health; Risk-Taking; Tenofovir | 2007 |
21 trial(s) available for tenofovir and AIDS Seroconversion
Article | Year |
---|---|
Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression.
Topics: Adolescent; Adult; Anti-HIV Agents; Biomarkers; CD4-CD8 Ratio; Chemokines; Cohort Studies; Disease Progression; Double-Blind Method; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Immunity; Prognosis; South Africa; Tenofovir; Treatment Outcome; Viral Load; Young Adult | 2022 |
Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans.
Topics: Adenine; Adult; African People; Alanine; Anti-HIV Agents; HIV Infections; HIV Seropositivity; Humans; Pharmacogenetics; Tenofovir | 2023 |
Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR): a random
Topics: Adenine; Adolescent; Adult; Aged; Anti-HIV Agents; Anti-Retroviral Agents; Emtricitabine; Female; Heterocyclic Compounds, 4 or More Rings; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant, Newborn; Injection Site Reaction; Male; Middle Aged; Rilpivirine; RNA; Tenofovir; Viral Load; Young Adult | 2023 |
Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study.
Topics: Adenine; Adolescent; Adult; Aged; Alanine; Amides; Anti-HIV Agents; Black or African American; Drug Combinations; Emtricitabine; Female; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Piperazines; Pyridones; RNA; Tenofovir; United States; Viral Load | 2021 |
Detection of new HIV infections in a multicentre HIV antiretroviral pre-exposure prophylaxis trial.
Topics: Anti-HIV Agents; Double-Blind Method; Drug Combinations; Emtricitabine; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Pre-Exposure Prophylaxis; Tenofovir | 2017 |
HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial.
Topics: Adult; CD4 Lymphocyte Count; Disease Progression; Female; HIV Infections; HIV Seropositivity; Humans; Placebos; Reverse Transcriptase Inhibitors; Tenofovir; Viral Load; Young Adult | 2017 |
Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.
Topics: Adult; Anti-HIV Agents; Dysbiosis; Emtricitabine; Female; Gardnerella vaginalis; HIV Infections; HIV Seropositivity; HIV-1; Humans; Kenya; Microbiota; Pre-Exposure Prophylaxis; Prospective Studies; Sexual Partners; Tenofovir; Uganda; Vagina; Vaginosis, Bacterial | 2017 |
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Emtricitabine; Female; HIV Infections; HIV Seropositivity; Humans; Incidence; Male; Mass Screening; Middle Aged; Research Design; South Africa; Tenofovir; Treatment Outcome; Young Adult | 2018 |
Switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from dolutegravir plus abacavir and lamivudine in virologically suppressed adults with HIV-1: 48 week results of a randomised, double-blind, multicentre, active-controlled, phas
Topics: Adult; Aged; Amides; Anti-HIV Agents; Dideoxynucleosides; Double-Blind Method; Drug Substitution; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Emtricitabine; Female; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Sustained Virologic Response; Tenofovir; Viral Load; Young Adult | 2018 |
Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa.
Topics: Adenine; Adult; Africa, Eastern; Anti-HIV Agents; Cohort Studies; Deoxycytidine; Emtricitabine; Family Characteristics; Female; HIV Infections; HIV Seropositivity; Humans; Male; Medication Adherence; Multivariate Analysis; Organophosphonates; Regression Analysis; Tenofovir | 2013 |
HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.
Topics: Adenine; Adult; Anti-HIV Agents; Biomarkers; Cohort Studies; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV Seropositivity; Humans; Male; Medication Adherence; Organophosphonates; Predictive Value of Tests; Proportional Hazards Models; Tenofovir; Young Adult | 2014 |
Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or dual-agent preexposure prophylaxis.
Topics: Adenine; Anti-HIV Agents; Anti-Retroviral Agents; Deoxycytidine; Double-Blind Method; Drug Resistance, Viral; Emtricitabine; HIV Infections; HIV Seropositivity; HIV-1; Humans; Organophosphonates; Risk; Tenofovir | 2015 |
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Topics: Adenine; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Africa South of the Sahara; Anti-Retroviral Agents; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Medication Adherence; Middle Aged; Organophosphonates; Pre-Exposure Prophylaxis; Surveys and Questionnaires; Tenofovir; Young Adult | 2015 |
Efficacy and safety of tenofovir-containing antiretroviral therapy in women who acquired HIV while enrolled in tenofovir gel prophylaxis trials.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Emtricitabine; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Patient Safety; Pregnancy; Primary Prevention; RNA, Viral; South Africa; Tenofovir; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Viral Load; Zidovudine | 2017 |
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Topics: Adenine; Administration, Oral; Adolescent; Adult; Anti-HIV Agents; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Follow-Up Studies; HIV; HIV Antibodies; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Nausea; Organophosphonates; Patient Compliance; RNA, Viral; Tenofovir; Transsexualism; Young Adult | 2010 |
Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Cohort Studies; Deoxycytidine; Emtricitabine; Female; Heterosexuality; HIV Infections; HIV Seronegativity; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Risk-Taking; Sexual Behavior; Tenofovir; Young Adult | 2011 |
What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples.
Topics: Adenine; Administration, Oral; Adult; Anti-HIV Agents; Attitude to Health; Deoxycytidine; Emtricitabine; Female; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Interpersonal Relations; Male; Medication Adherence; Middle Aged; Organophosphonates; Sexual Partners; Tenofovir; Uganda; Young Adult | 2012 |
Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
Topics: Abortion, Spontaneous; Adenine; Adult; Anti-HIV Agents; Body Height; Body Weight; Breast Feeding; Burns; Cause of Death; Child, Preschool; Congenital Abnormalities; Drug Combinations; Female; Follow-Up Studies; Fractures, Bone; Growth; HIV Infections; HIV Seropositivity; Humans; Infant; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Measles; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Respiratory Tract Infections; Tenofovir; Uganda; Zidovudine; Zimbabwe | 2012 |
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
Topics: Adenine; Adolescent; Adult; Anti-Retroviral Agents; Bone Density; Contraception Behavior; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV Seropositivity; HIV-1; HIV-2; Humans; Kaplan-Meier Estimate; Male; Organophosphonates; Proportional Hazards Models; RNA, Viral; Sexual Behavior; Tenofovir; Viral Load; Young Adult | 2012 |
Preexposure prophylaxis for HIV infection among African women.
Topics: Adenine; Adolescent; Adult; Alanine Transaminase; Anti-Retroviral Agents; Case-Control Studies; Deoxycytidine; Double-Blind Method; Drug Combinations; Drug Resistance, Viral; Emtricitabine; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Incidence; Kaplan-Meier Estimate; Medication Adherence; Organophosphonates; Risk-Taking; RNA, Viral; Sexual Behavior; Tenofovir; Treatment Failure; Viral Load; Young Adult | 2012 |
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Topics: Adenine; Adolescent; Adult; Anti-Retroviral Agents; Contraception Behavior; Deoxycytidine; Double-Blind Method; Drug Combinations; Drug Resistance, Viral; Emtricitabine; Female; Heterosexuality; HIV Infections; HIV Seropositivity; HIV-1; Humans; Incidence; Male; Middle Aged; Organophosphonates; Pregnancy; RNA, Viral; Sexual Behavior; Tenofovir; Young Adult | 2012 |
59 other study(ies) available for tenofovir and AIDS Seroconversion
Article | Year |
---|---|
Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19).
Topics: Adenine; Adult; Anti-HIV Agents; COVID-19 Drug Treatment; Drug Interactions; Emtricitabine; Female; HIV Infections; HIV Seropositivity; Humans; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; SARS-CoV-2; Tenofovir | 2022 |
Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study.
Topics: Adult; Anti-HIV Agents; Anti-Retroviral Agents; Drug Resistance; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Malawi; Oxazines; Piperazines; Prospective Studies; Pyridones; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Viral Load | 2022 |
Performance of Creatinine- and Cystatin C-Based Equations for Glomerular Filtration Rate Estimation in HIV-1-Infected Individuals Receiving Dolutegravir + Tenofovir Disoproxil Fumarate + Lamivudine as Initial Antiretroviral Therapy: A Retrospective Observ
Topics: Adult; Creatinine; Cystatin C; Female; Glomerular Filtration Rate; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Oxazines; Piperazines; Pyridones; Renal Insufficiency, Chronic; Retrospective Studies; Tenofovir | 2022 |
Economic evaluation of doravirine/tenofovir disoproxil fumarate/lamivudine for HIV-1-infected adults in Russia: a cost-minimization and budget impact analysis.
Topics: Adult; Anti-HIV Agents; Cost-Benefit Analysis; Drug Combinations; Drugs, Essential; Emtricitabine; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; RNA, Viral; Tenofovir; Viral Load | 2022 |
Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Week 24 Results From IMPAACT 2014.
Topics: Adolescent; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Child; Emtricitabine; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Pyridones; RNA, Viral; Tablets; Tenofovir | 2023 |
Persistently elevated alkaline phosphatase could be related to Paget's disease of bone in a patient receiving tenofovir disoproxil fumarate.
Topics: Adenine; Adult; Alkaline Phosphatase; Anti-HIV Agents; HIV Infections; HIV Seropositivity; Humans; Middle Aged; Osteitis Deformans; Tenofovir | 2023 |
Antiviral activity of tenofovir alafenamide (TAF) against HIV-1 clinical isolates harboring K65R.
Topics: Alanine; Anti-HIV Agents; HIV Infections; HIV Seropositivity; HIV-1; Humans; Prodrugs; Reverse Transcriptase Inhibitors; Tenofovir | 2023 |
Heart transplantation and human immunodeficiency virus-navigating drug-drug interactions: a case report.
Topics: Anti-HIV Agents; Emtricitabine; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Tenofovir | 2023 |
Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens.
Topics: Cameroon; HIV Seropositivity; HIV-1; Humans; Lamivudine; Tenofovir | 2023 |
Adherence determination using urine-tenofovir point-of-care testing and pharmacy refill records: A cross-sectional study.
Topics: Adult; Anti-HIV Agents; Cross-Sectional Studies; HIV Infections; HIV Seropositivity; Humans; Medication Adherence; Nigeria; Pharmacy; Tenofovir | 2023 |
Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide.
Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cobicistat; Dyslipidemias; Emtricitabine; Female; HIV Seropositivity; Humans; Lipids; Male; Middle Aged; Quinolones; Retrospective Studies; Tenofovir; Weight Gain | 2020 |
HIV-1 superinfection in a patient with known HIV-2 - A case report.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cobicistat; Darunavir; Emtricitabine; Female; HIV Infections; HIV Seropositivity; HIV-1; HIV-2; Humans; Male; Middle Aged; Superinfection; Tenofovir; Treatment Outcome | 2020 |
Failure of pre-exposure prophylaxis with daily tenofovir/emtricitabine and the scenario of delayed HIV seroconversion.
Topics: Anti-HIV Agents; Emtricitabine; Female; HIV Infections; HIV Seropositivity; Humans; Male; Medication Adherence; Pre-Exposure Prophylaxis; Seroconversion; Tenofovir; Treatment Failure; Young Adult | 2020 |
Design and methods of the prevalence and pharmacogenomics of tenofovir nephrotoxicity in HIV-positive adults in south-western Nigeria study.
Topics: Adult; Anti-HIV Agents; Black People; Case-Control Studies; Cross-Sectional Studies; Female; HIV Seropositivity; HIV-1; HIV-2; Humans; Kidney Diseases; Kidney Tubules; Male; Nigeria; Pharmacogenomic Testing; Polymorphism, Single Nucleotide; Prevalence; Research Design; Risk Factors; Socioeconomic Factors; Tenofovir; Viral Load | 2020 |
Association of tenofovir disoproxil fumarate with primary allograft survival in HIV-positive kidney transplant recipients.
Topics: Adult; Allografts; Cohort Studies; Female; Graft Survival; HIV Infections; HIV Seropositivity; Humans; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Tenofovir | 2017 |
Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report.
Topics: Adenine; Anti-HIV Agents; Emtricitabine; HIV Infections; HIV Seropositivity; HIV-1; Homosexuality, Male; Humans; Lymphogranuloma Venereum; Male; Medication Adherence; Middle Aged; Organophosphates; Pre-Exposure Prophylaxis; RNA, Viral; Tenofovir; Transgender Persons; Urinary Tract Infections | 2017 |
Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Multiple, Viral; Emtricitabine; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Medication Adherence; Pre-Exposure Prophylaxis; RNA, Viral; Tenofovir; Thailand | 2018 |
A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015-2017.
Topics: Adenine; Adult; Alanine; Anti-HIV Agents; Cohort Studies; Female; Fumarates; Germany; HIV Seropositivity; Hospitals, University; Humans; Male; Middle Aged; Retrospective Studies; Tenofovir; Weight Gain; Weight Loss | 2019 |
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cohort Studies; Darunavir; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lamivudine; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Retrospective Studies; Ritonavir; Tenofovir; Treatment Outcome; Viral Load | 2019 |
Inflammation status in HIV-positive individuals correlates with changes in bone tissue quality after initiation of ART.
Topics: Absorptiometry, Photon; Adult; Anti-HIV Agents; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Cohort Studies; Female; HIV Infections; HIV Seropositivity; Humans; Inflammation; Male; Spain; Tenofovir | 2019 |
Option B plus antiretroviral therapy adherence and associated factors among HIV positive pregnant women in Southern Ethiopia.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Developing Countries; Directive Counseling; Drug Therapy, Combination; Ethiopia; Female; Health Services Accessibility; HIV Seropositivity; Hospitals, Public; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Medication Adherence; Pregnancy; Prenatal Care; Surveys and Questionnaires; Tenofovir; Time Factors; Travel; Young Adult | 2019 |
Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009.
Topics: Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studies; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Emtricitabine; Europe; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Lamivudine; Lopinavir; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir; Time Factors; United States | 2013 |
Pre-exposure prophylaxis for conception (PrEP-C) as a risk reduction strategy in HIV-positive men and HIV-negative women in the UK.
Topics: Adenine; Adult; Anti-HIV Agents; Deoxycytidine; Emtricitabine; Family Characteristics; Female; Fertility; HIV Seronegativity; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; Male; Middle Aged; Organophosphonates; Preconception Care; Pregnancy; Pregnancy Outcome; Risk Reduction Behavior; Semen; Semen Analysis; Tenofovir; Viral Load | 2014 |
Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices.
Topics: Adenine; Anti-HIV Agents; Circumcision, Male; Cost-Benefit Analysis; Female; Forecasting; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV Seropositivity; Humans; Incidence; Male; Models, Economic; Organophosphonates; Prevalence; South Africa; Tenofovir | 2014 |
An interesting case of 'diabetic foot ulcer' in an HIV-positive patient.
Topics: Adenine; Aged; Antiretroviral Therapy, Highly Active; Biopsy; Deoxycytidine; Diabetes Mellitus, Type 2; Diabetic Foot; Emtricitabine; Herpesvirus 8, Human; HIV Infections; HIV Seropositivity; Humans; Male; Organophosphonates; Sarcoma, Kaposi; Skin Neoplasms; Tenofovir; Treatment Outcome; Ulcer | 2015 |
Effect of antiretroviral HIV therapy on hepatitis B virus replication and pathogenicity.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Coinfection; Deoxycytidine; Emtricitabine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Inflammation; Organophosphonates; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; tat Gene Products, Human Immunodeficiency Virus; Tenofovir; Virus Replication; vpr Gene Products, Human Immunodeficiency Virus | 2014 |
Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study.
Topics: Adult; Antiviral Agents; Cohort Studies; Comorbidity; Disease Progression; Female; France; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; HIV Infections; HIV Seronegativity; HIV Seropositivity; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Logistic Models; Male; Middle Aged; Multivariate Analysis; Reference Values; Retrospective Studies; Risk Assessment; Statistics, Nonparametric; Survival Analysis; Tenofovir; Treatment Outcome | 2015 |
Estimating the cost-effectiveness of pre-exposure prophylaxis to reduce HIV-1 and HSV-2 incidence in HIV-serodiscordant couples in South Africa.
Topics: Adenine; Anti-HIV Agents; Cost-Benefit Analysis; Couples Therapy; Family Characteristics; Female; HIV Seropositivity; HIV Seroprevalence; HIV-1; HIV-2; Humans; Male; Organophosphonates; Pre-Exposure Prophylaxis; South Africa; Tenofovir | 2015 |
Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Drug Combinations; Emtricitabine; Female; HIV Infections; HIV Seropositivity; Humans; Incidence; Lamivudine; Lopinavir; Male; Medication Adherence; Middle Aged; Post-Exposure Prophylaxis; Quebec; Ritonavir; Tenofovir; Young Adult; Zidovudine | 2015 |
Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Body Weight; CD4-Positive T-Lymphocytes; Cohort Studies; Cyclopropanes; Disclosure; Female; HIV Infections; HIV Seropositivity; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Nevirapine; Retrospective Studies; Tenofovir; Treatment Outcome; Uganda | 2016 |
Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course.
Topics: Adenine; Adult; Amino Acid Sequence; Anti-HIV Agents; CD4 Lymphocyte Count; Chemoprevention; Deoxycytidine; Drug Resistance, Viral; Emtricitabine; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; HLA Antigens; Humans; Intestinal Mucosa; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Organophosphonates; Phylogeny; Receptors, CCR5; Sequence Alignment; Tenofovir; Time Factors; Viral Load; Viremia | 2008 |
Tenofovir-related acute kidney injury and proximal tubule dysfunction precipitated by diclofenac: a case of drug-drug interaction.
Topics: Acute Kidney Injury; Adenine; Anti-HIV Agents; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Diagnosis, Differential; Diclofenac; Drug Synergism; Drug Therapy, Combination; Fanconi Syndrome; Female; HIV Antibodies; HIV Seropositivity; HIV-1; Humans; Kidney Tubules, Proximal; Middle Aged; Organophosphonates; Tenofovir | 2009 |
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.
Topics: Adenine; Adult; Anti-HIV Agents; Atazanavir Sulfate; Disease Progression; Epidemiologic Methods; Female; Glomerular Filtration Rate; HIV Seropositivity; HIV-1; Humans; Indinavir; Kidney Failure, Chronic; Male; Middle Aged; Oligopeptides; Organophosphonates; Pyridines; Reverse Transcriptase Inhibitors; Tenofovir | 2010 |
Antiretroviral vaginal gel shows promise against HIV.
Topics: Adenine; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Clinical Trials as Topic; Female; Gels; HIV Infections; HIV Seropositivity; Humans; Incidence; Infectious Disease Transmission, Vertical; Medication Adherence; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; South Africa; Tenofovir; Vagina | 2010 |
Cystatin C and baseline renal function among HIV-infected persons in the SUN Study.
Topics: Adenine; Adult; Anti-HIV Agents; Body Mass Index; CD4 Lymphocyte Count; Cohort Studies; Cross-Sectional Studies; Cystatin C; Female; Glomerular Filtration Rate; Hepatitis C; HIV Seropositivity; Humans; Hypertension; Male; Organophosphonates; Prospective Studies; Renal Insufficiency; Ritonavir; Tenofovir | 2012 |
Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir.
Topics: Adenine; Adult; Anti-HIV Agents; Bone Density; Deoxycytidine; Dideoxynucleosides; Emtricitabine; Female; Follow-Up Studies; HIV Seropositivity; Humans; Lamivudine; Longitudinal Studies; Male; Organophosphonates; Parathyroid Hormone; Tenofovir; Vitamin D; Vitamin D Deficiency | 2012 |
Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients.
Topics: Adenine; Adult; Anti-HIV Agents; Atazanavir Sulfate; Deoxycytidine; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Oligopeptides; Organophosphonates; Pyridines; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome | 2011 |
Battles with donors cloud Malawi's HIV prevention plan.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Charities; Cyclopropanes; Drug Costs; Drug Therapy, Combination; Female; Health Policy; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; International Cooperation; Lamivudine; Malawi; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2011 |
Iatrogenic Cushing syndrome after a single intramuscular corticosteroid injection and concomitant protease inhibitor therapy.
Topics: Adenine; Adrenal Insufficiency; Adult; Atazanavir Sulfate; Cushing Syndrome; Cytochrome P-450 Enzyme Inhibitors; Female; HIV Protease Inhibitors; HIV Seropositivity; Humans; Iatrogenic Disease; Injections, Intramuscular; Lamivudine; Oligopeptides; Organophosphonates; Pruritus; Pyridines; Ritonavir; Tenofovir; Triamcinolone Acetonide | 2011 |
Scientific report: highlights of 24th ICAR, 8-11 May 2011, Sofia, Bulgaria.
Topics: Adenine; Animals; Antiviral Agents; Arenavirus; Chemistry, Pharmaceutical; Communicable Diseases, Emerging; Cytosine; Flavivirus; Hepacivirus; HIV Seropositivity; Humans; Organophosphonates; Prodrugs; Smallpox; Tenofovir; Virus Replication | 2011 |
In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone and Bones; Child; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Female; Fetus; HIV; HIV Infections; HIV Seropositivity; Humans; Infant; Infectious Disease Transmission, Vertical; Italy; Male; Observation; Organophosphonates; Pregnancy; Reverse Transcriptase Inhibitors; Tenofovir | 2011 |
Hyperhidrosis related to nevirapine therapy.
Topics: Adenine; Aged; Anti-HIV Agents; Drug Eruptions; HIV Seropositivity; Humans; Hyperhidrosis; Lamivudine; Male; Nevirapine; Organophosphonates; Tenofovir | 2012 |
Fibroblast growth factor 23 in hypophosphataemic HIV-positive adults on tenofovir.
Topics: Adenine; Anti-HIV Agents; Calcium; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; HIV Seropositivity; Humans; Hypophosphatemia; Kidney Tubules, Proximal; Male; Middle Aged; Organophosphonates; Parathyroid Hormone-Related Protein; Phosphates; Tenofovir | 2012 |
High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen.
Topics: Adenine; Adult; Arginine; CD4 Lymphocyte Count; Cohort Studies; Drug Resistance, Viral; Female; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Lamivudine; Lysine; Male; Mutation; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; South Africa; Stavudine; Tenofovir; Treatment Failure; Viral Load | 2012 |
Natural killer cell function in women at high risk for HIV acquisition: insights from a microbicide trial.
Topics: Adenine; Administration, Topical; Adult; Anti-HIV Agents; Case-Control Studies; CD4-Positive T-Lymphocytes; Cell Proliferation; Clinical Trials as Topic; Disease Susceptibility; Female; Flow Cytometry; Herpes Genitalis; HIV Seropositivity; HIV-1; Humans; Interferon-gamma; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Middle Aged; Organophosphonates; Risk Assessment; Sexual Behavior; South Africa; Tenofovir; Vaginal Creams, Foams, and Jellies | 2012 |
Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.
Topics: Adenine; Adult; AIDS-Associated Nephropathy; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Creatinine; Female; Glomerular Filtration Rate; Hepatitis C; HIV Seropositivity; HIV-1; Humans; Incidence; Male; Middle Aged; Organophosphonates; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Factors; Ritonavir; Tenofovir; United States; Viral Load | 2012 |
Is etravirine and two nucleosides an option for HIV with an isolated K103N mutation?
Topics: Adenine; Adult; Anti-HIV Agents; Asparagine; Deoxycytidine; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Emtricitabine; Female; Genotype; HIV Seropositivity; HIV-1; Humans; Lysine; Male; Mutation; Nitriles; Organophosphonates; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Tenofovir | 2013 |
Tenofovir use and pregnancy among women initiating HAART.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; Follow-Up Studies; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; Middle Aged; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Proportional Hazards Models; Prospective Studies; Risk Assessment; South Africa; Tenofovir; Treatment Outcome; Women's Health | 2012 |
Blunted fetal growth by tenofovir in late pregnancy.
Topics: Adenine; Adult; Anti-HIV Agents; Asian People; Bone Density; Female; Fetal Growth Retardation; Hepatitis B; HIV Seropositivity; Humans; Infant, Newborn; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2012 |
Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy.
Topics: Adenine; Adult; Cross-Sectional Studies; Drug Administration Schedule; Drug Resistance, Viral; Female; Genotype; HIV Seropositivity; HIV-1; Humans; Male; Mutation, Missense; Nigeria; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Tenofovir; Treatment Failure; Viral Load; Zidovudine | 2013 |
Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up.
Topics: Adenine; Adult; Anti-HIV Agents; Canada; Cohort Studies; Female; Follow-Up Studies; Glomerular Filtration Rate; HIV Infections; HIV Seropositivity; Humans; Kidney Diseases; Male; Organophosphonates; Proportional Hazards Models; Tenofovir | 2013 |
Sexually transmitted infection with an immune-escape mutant hepatitis B virus in an hepatitis B virus-vaccinated individual with acute HIV-hepatitis C virus infection.
Topics: Acute Disease; Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Darunavir; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis C; HIV Seropositivity; Homosexuality, Male; Humans; Male; Organophosphonates; Sulfonamides; Tenofovir; Treatment Outcome; Unsafe Sex; Viral Load | 2013 |
Fanconi syndrome and renal failure induced by tenofovir: a first case report.
Topics: Adenine; Anti-HIV Agents; Fanconi Syndrome; Female; HIV Seropositivity; Humans; Middle Aged; Organophosphonates; Organophosphorus Compounds; Renal Insufficiency; Tenofovir | 2002 |
Fanconi-like syndrome and rhabdomyolysis in a person with HIV infection on highly active antiretroviral treatment including tenofovir.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Fanconi Syndrome; Female; HIV Seropositivity; Humans; Middle Aged; Organophosphonates; Organophosphorus Compounds; Rhabdomyolysis; Tenofovir | 2003 |
Fanconi syndrome and acute renal failure in a patient treated with tenofovir: a call for caution.
Topics: Acute Kidney Injury; Adenine; Adult; Anti-HIV Agents; Fanconi Syndrome; HIV Seropositivity; HIV-1; Humans; Male; Organophosphonates; Organophosphorus Compounds; Tenofovir | 2004 |
Moving toward assured access to treatment in microbicide trials. Global Campaign for Microbicides.
Topics: Adenine; Anti-HIV Agents; Cambodia; Cameroon; Clinical Trials as Topic; Consensus Development Conferences as Topic; Global Health; Health Policy; Health Services Accessibility; HIV Infections; HIV Seropositivity; Humans; International Agencies; Nigeria; Organophosphonates; Patient Rights; Political Systems; Politics; Randomized Controlled Trials as Topic; Refusal to Treat; Risk-Taking; Social Justice; Tenofovir; United Nations | 2006 |
Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Black People; Cholesterol; Cross-Sectional Studies; Cyclopropanes; Didanosine; Dideoxynucleosides; Drug Therapy, Combination; Fasting; Female; Hispanic or Latino; HIV Infections; HIV Protease Inhibitors; HIV Seronegativity; HIV Seropositivity; HIV-1; Humans; Indinavir; Lamivudine; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Multivariate Analysis; Nelfinavir; Nevirapine; Organophosphonates; Ritonavir; Stavudine; Tenofovir; Triglycerides; United States; White People | 2007 |
FDA approves tenofovir.
Topics: Adenine; Drug Approval; HIV Seropositivity; Humans; Organophosphonates; Organophosphorus Compounds; Prodrugs; Reverse Transcriptase Inhibitors; Tenofovir; United States; United States Food and Drug Administration | 2002 |
Use of tenofovir.
Topics: Adenine; Clinical Trials as Topic; HIV Seropositivity; Humans; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir; Viral Load | 2002 |